BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 13.81% |
| 3 | Financials | 13.25% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Noble Corp
NE
$7.04B
| $21.3M | ﹤0.01% |
786,305
+762,922
| +3,263% | +$18.2M |
|
3227
National Grid
NGG
$81.6B
| $21.3M | ﹤0.01% |
403,280
+3,048
| +0.8% | +$175K |
|
|
CS
3228
DELISTED
Credit Suisse Group
CS
| $21.3M | ﹤0.01% |
2,155,993
+204,139
| +10% | +$2.09M |
|
|
NPKI
3229
NPK International
NPKI
$1.19B
| $21.2M | ﹤0.01% |
6,423,218
-125,844
| -2% | -$355K |
|
3230
Spruce Power Holding Corp
SPRU
$38.9M
| $21.2M | ﹤0.01% |
429,588
-24,533
| -5% | -$1.31M |
|
3231
Lyell Immunopharma
LYEL
$347M
| $21.1M | ﹤0.01% |
71,345
+58,965
| +476% | +$17.7M |
|
3232
Aveanna Healthcare
AVAH
$2.46B
| $21.1M | ﹤0.01% |
2,626,175
+59,151
| +2% | +$573K |
|
3233
First Bancorp
FNLC
$402M
| $21M | ﹤0.01% |
720,366
-22,086
| -3% | -$640K |
|
|
BNFT
3234
DELISTED
Benefitfocus, Inc.
BNFT
| $20.9M | ﹤0.01% |
1,882,448
-400,703
| -18% | -$4.87M |
|
|
ATNX
3235
DELISTED
Athenex, Inc. Common Stock
ATNX
| $20.9M | ﹤0.01% |
346,970
+10,202
| +3% | +$742K |
|
|
SIEN
3236
DELISTED
Sientra, Inc.
SIEN
| $20.8M | ﹤0.01% |
362,764
-1,481
| -0.4% | -$101K |
|
3237
Cytosorbents Corp
CTSO
$22.8M
| $20.8M | ﹤0.01% |
2,558,792
-82,374
| -3% | -$669K |
|
3238
Nokia
NOK
$59B
| $20.8M | ﹤0.01% |
3,807,745
+513,000
| +16% | +$2.98M |
|
3239
VanEck Semiconductor ETF
SMH
$72.5B
| $20.7M | ﹤0.01% |
161,524
-146
| -0.1% | -$19.2K |
|
|
OCFT
3240
DELISTED
OneConnect Financial Technology
OCFT
| $20.7M | ﹤0.01% |
504,609
+32,300
| +7% | +$2.05M |
|
3241
ClearPoint Neuro
CLPT
$463M
| $20.7M | ﹤0.01% |
1,163,572
+14,362
| +1% | +$269K |
|
3242
United States Lime & Minerals
USLM
$3.42B
| $20.6M | ﹤0.01% |
853,580
-145,275
| -15% | -$4.04M |
|
3243
NVE Corp
NVEC
$591M
| $20.6M | ﹤0.01% |
322,198
-1,586
| -0.5% | -$113K |
|
|
HCAR
3244
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $20.6M | ﹤0.01% |
2,112,000
| – | – |
|
|
TCS
3245
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $20.6M | ﹤0.01% |
144,014
-261
| -0.2% | -$43.8K |
|
|
LKFT
3246
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $20.5M | ﹤0.01% |
389,759
-17,416
| -4% | -$1.03M |
|
3247
BlackRock Intermediate Muni Income Bond ETF
INMU
$548M
| $20.5M | ﹤0.01% |
800,000
| – | – |
|
|
GNTY
3248
DELISTED
Guaranty Bancshares
GNTY
| $20.5M | ﹤0.01% |
571,096
-6,026
| -1% | -$205K |
|
|
INFI
3249
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $20.5M | ﹤0.01% |
5,983,489
-57,855
| -1% | -$178K |
|
|
MSON
3250
DELISTED
Misonix Inc
MSON
| $20.4M | ﹤0.01% |
807,643
-21,395
| -3% | -$529K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.